Medicine & Health

WashU Medicine has received renewal of a prestigious National Cancer Institute grant. Led by Daniel Link, MD, it provides funding for translational research into new therapies for patients with blood cancers.

WashU senior Emma Lembke, 22, has earned a spot on Forbes’ “30 Under 30” social media list. Lembke co-founded  Log Off, an organization for and by teens who want to raise awareness about social media’s impact on mental health.

In recognition of a $50 million gift from Andrew and Barbara Taylor, the neurosurgery department at WashU Medicine has been named the Taylor Family Department of Neurosurgery.

Glioblastoma is an aggressive, incurable brain cancer that is the most common malignant brain tumor in adults. New research from Washington University in St. Louis shows that glioblastoma has an internal clock and syncs its daily rhythms to match — and take advantage of — the rhythms of its host.

Researchers at Washington University are looking to find new ways to design vaccines to protect against inflammation in the brain that causes dementia.

WashU Medicine secured $683 million in research funding from the National Institutes of Health (NIH) in 2024, placing the school at No. 2 in NIH funding nationwide for the second year in a row.

Volunteering, even a small amount, is linked to slower age acceleration for both retirees and working people, finds a new study from the Brown School at Washington University in St. Louis.

Burel R. Goodin, a professor of anesthesiology at WashU Medicine, has received more than $3 million from the National Institutes of Health (NIH) to support postdoctoral training.

A new, artificial intelligence-based method of analyzing mammograms, developed by researchers at WashU Medicine, identified individuals at high risk of developing breast cancer more accurately than the standard, questionnaire-based method did.

Results from a clinical trial conducted at WashU Medicine showed adding the investigational drug itacitinib to standard care for “half-matched” stem cell transplantation may reduce rates of graft-versus-host disease.